Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Fandom Sports Set to Launch NFT Marketplace Including Gamification & Rewards

THE PLATFORM PLANS TO REWARD FAN ENGAGEMENT WITH UTILITY AND UNIQUE CUSTOM NFTS Fandom Sports Media Corporation ( CSE: FDM , Forum ) , a Vancouver-based gaming and entertainment company, is all set to launch its all-ages gamification platform that will reward fan engageme...

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change

Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO. After U.S. markets closed yesterday afternoon, global molecular diagnostics and precision medicine company Myriad Genetics Inc. (M...

First Private Sector Energy Storage Deployment Contract for Zinc8 Energy Solutions

Second Commercial Agreement in New York City Less than 2 months after the public sector company NYPA (New York Power Authority) announced a Collaboration Agreement with Zinc8 Energy Solutions, a second energy storage deployment contract has now been executed, th...

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

A Ladenburg Thalmann report reviewed the study design and purpose. In March 11 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc. (VIVE:NASDAQ) finished enrollment for the VIVEVE II trial of 250 patients across 19 clinical locati...

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...

5 Ways Tech Startups can Compete with the Industry Leaders

It is a common thing for any established industry to be dominated by several large companies. There are eBay and Amazon for eCommerce, Facebook and Snapchat for social media, Uber and Lyft for transportation, etc. Beating such competitors is a tough challenge every ...

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...

Fed Cut Equities Stimulus 86% This Week and Stocks Are Falling

What happens to the global markets when the US Fed begins to weaken stimulus activity and when the global markets must begin to function on their own? Are the global markets capable of sustaining current price levels without the Fed supporting them? A recent news article s...

A ‘Barrier’ to Better Health

(Click image to play podcast) The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body bu...

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
1 2 3 4 5 6 7 8 9 10 ...